● Recruiting

Cardiac Injury Due to Anthracycline in Paediatric Oncological Patients

Condition: Heart Injuries · Anthracycline · Sponsor: IRCCS Burlo Garofolo

PhaseN/A

Planned participants22

Who can joinAll sexes, 0 Years to 18 Years

Healthy volunteersNo

About this study

The study investigates the role of echocardiography and of serum biomarkers (NT-proBNP, cardiac Troponin-I) in predicting cardiac injury in a cohort of paediatric oncological patients treated with Anthracycline chemotherapy.

This description comes directly from the study's public registry record.

Talk to the study team

Thomas Caiffa, MD · +39 0403785248 · thomas.caiffa@burlo.trieste.it

Always discuss trial participation with your own doctor first.

Locations (1)

IRCCS Burlo Garofolo

Trieste, Italy, Italy

Recruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06898320